IMMUNE THROMBOCYTOPENIA (ITP)
Clinical trials for IMMUNE THROMBOCYTOPENIA (ITP) explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIA (ITP) trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA (ITP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for ITP: can an infusion boost low platelets fast?
Disease control Recruiting nowThis study tests a medicine called V-IMMUNE® (a type of human immunoglobulin given through a vein) to see if it can safely raise platelet counts in people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risk. About 31 a…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE3 • Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. • Aim: Disease control
Last updated May 26, 2026 04:54 UTC
-
New antibody drug offers hope for stubborn blood disorders
Disease control Recruiting nowThis study tests a new drug called CM336 in people with autoimmune cytopenia, a condition where the immune system attacks blood cells. The drug aims to control the disease by targeting certain immune cells. About 158 adults with relapsed or refractory forms of immune thrombocytop…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE1, PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated May 26, 2026 04:52 UTC
-
New pill could help ITP patients avoid bleeding risks
Disease control Recruiting nowThis study tests an experimental drug called pirtobrutinib in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, raising bleeding risk. The first part checks safety and side effects; the second compares different doses to a placebo …
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 04:51 UTC
-
New combo therapy aims to boost platelet counts in ITP patients
Disease control Recruiting nowThis study tests whether adding teriflunomide to high-dose dexamethasone works better than dexamethasone alone for adults newly diagnosed with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. About 132 participants will rece…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 26, 2026 04:51 UTC
-
Experimental CAR-T therapy targets lupus, ITP, and myositis in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called BZE2204 for people with three autoimmune diseases: lupus, ITP, and inflammatory myopathies. The treatment uses the patient's own immune cells, modified to attack faulty immune cells that cause the disease. The main goals are to …
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: EARLY_PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated May 26, 2026 04:47 UTC
-
New drug targets immune attack in six diseases
Disease control Recruiting nowThis early-stage trial tests a new drug called RAY121 in 144 adults with one of six immune diseases: antiphospholipid syndrome, bullous pemphigoid, Behçet's syndrome, dermatomyositis, immune-mediated necrotizing myopathy, or immune thrombocytopenia. The drug blocks a part of the …
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
New drug hopes to raise platelet counts in teens with chronic bleeding disorder
Disease control Recruiting nowThis study tests an IV drug called efgartigimod in teens aged 12 to 18 who have had immune thrombocytopenia (ITP) for over a year. ITP causes low platelet counts, leading to bruising and bleeding. The goal is to find the right dose and see if it safely raises platelet levels. Par…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
New pill aims to boost platelets in hard-to-treat ITP patients
Disease control Recruiting nowThis study tests an experimental drug called DZD8586 in adults with primary immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. Participants must have failed at least one standard treatment and have low platelet counts. T…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
New drug budoprutug aims to boost platelets in ITP patients
Disease control Recruiting nowThis study tests a new drug, budoprutug, in 24 adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. The main goal is to check safety and find the right dose, while also seeing if it helps raise platelet counts.…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE1, PHASE2 • Sponsor: Climb Bio, Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC